Impact of Biotechnology onPredictive Oncology & Intervention Strategies
Montréal, QuébecAugust 16-19, 2003   rescheduled

Please Note: The meeting previously scheduled for August 2003 in Montreal has been rescheduled for February 7th - 10th, 2004 in Nice, France. [details]

This page will remain online for historical purposes.

Symposium Sponsors

The 2003 symposium is jointly cosponsored by the following groups:

Conseil québécois de lutte contre le cancer (CQLC)

Committees

The 2003 symposium is made possible through the work of the following individuals:

Program Committee

Helmut Bartsch, PhD
Deutsches Krebsforschungszentrum, Heidelberg, Germany
William T Beck, PhD
University of Illinois, Chicago IL
Ricardo Brentani, MD
Ludwig Institute for Cancer Research, Sao Paulo, Brazil
L Bubendorf, MD
Institute of Pathology, Basel, Switzerland
Guy de Thé, MD PhD
Institut Pasteur, Paris
S Edmonds, MD
National Cancer Institute of Canada, London, England
Eduardo L Franco, PhD DPH
McGill University Division Cancer Epidemiology, Montreal, Canada
Hirota Fujiki, MD
Tokushima Bunri University, Dept Biochemistry, Tokushima, Japan
Parviz Ghadirian, PhD
Centre de recherche du CHUM, Montreal, Canada
Robert A. Good, MD PhD DSc
All Children's Hospital, University South Florida, St Petersburg, FL
William C Hahn, MD PhD
Harvard - Brigham Hospital, Boston MA
John Horton, MD
Free Moffett Cancer Center, Tampa FL
Susumu Ikehara, MD PhD
Kansai Medical University, Osaka, Japan
Paul Kleihues, MD
IARC, Lyon, France
J Latreille, MD
Quebec Council for Cancer Control, Quebec, Canada
Anthony B. Miller, MB BChir
Deutsches Krebsforschungszentrum, Heidelberg, Germany
Herbert E. Nieburgs, MD
UMMS, Worcester MA
TO Philip, MD
Centre Leon Berard, Lyon
Frank J Rauscher III, PhD
Wistar Institute, Philadelphia, PA
NR Rose, MD
John Hopkins SPH,
Cecilia Sepulveda, MD MPH
WHO, Cancer Control Program, Geneva, Switzerland
Kenneth Stanley, PhD
WHO, Cancer Control Program, Geneva, Switzerland
Zongtang Sun, MD
National Laboratory Molecular Oncology, Chinese Academy Sciences, Beijing, China
Terrence Sullivan, MD
Canadian Strategy for Cancer Control, Toronto, Canada
Harry U. Vainio, MD
IARC, Lyon, France
Victor E. Valli, PhD DVM
College of Veterinary Medicine, University of Illinois Urbana, Champaign, IL

Organizing Committee

Guy de Thé, MD PhD
Institut Pasteur, Paris
SA Kay, MLS
ISPO, Worcester
T Manning, MPH
UMMS, Worcester
AJ Mastromarino, PhD
UTX MD Anderson Cancer Center,
Herbert E. Nieburgs, MD
UMMS, Worcester MA
Leonardo Santi, MD
National Cancer Institute Advanced Biotechnology Center, Genoa, Italy
Victor E. Valli, PhD DVM
College of Veterinary Medicine, University of Illinois Urbana, Champaign, IL

Advisory Committee

DS Alberts, A Albini, P Anglard, H Bartsch, C Baum, WT Beck, P Becker, EMJJ Berns, CR Boland, RR Brentani, WK Cavenee, LWK Chung, RJ Cristiano, SH Dairkee, AG Dalgleish, L Degos, C Dittrich, E Dmitrovsky, D Fabbro, A Fischer, AL Frank, L Frati, K Frenkel, AM Gewirtz, SA Geller, JB Gibbs, TR Gingeras, G Giraldo, JC Gluckman, P Gold, FJ Gonzolez, MM Gottardis, F Halberg, RB Hayes, M Henderson, PW Hinds, B Hirt, B Hoerni, M Hollstein, J Horton, WJM Hrushesky, R Hutter, P Hwu, S Ikehara, HL Ioachim, U Jaeger, P Keohavong, W Knapp, D Li, HT Lynch, P Lynch, G Maltoni, L Mao, T Maringer, F Marincola, T Minamoto, S Monfadini, MI Nerenberg, F Nestle, B Palcic, D Palli, DM Parkin, I Pastan, I Penn, Y Reisner, NR Rose, A Sarasin, A Sasco, AP Sappino, G Selivanova, JW Shay, K Sikora, P Sonneveld, DA Spandidos, MR Spitz, FM Stewart, H Tahara, JL Teillaud, L Terstappen, M Tubiana, VG Vogel, S Waxman, JH Weisburger, PH Wiernik, H Yamasaki

Local Committee

EL Franco PhD, McGill University
PR Band MD PhD, HPB Health Canada
P Ghadirian PhD, CHU Montréal
ML Tremblay MD, McGill University

National Committee

S Sutcliffe MD, British Columbia Cancer Angency
G Batist MD, McGill University
P Chartrand MD, Université de Montréal
S Edmonds MD, National Cancer Institute of Canada
A Fuks MD, McGill University
D Krewski PhD, Institute of Population Health
J Latreille MD, Québec Council for Cancer Control
G McKeownEyssen PhD, CCERN
H Morrison PhD, CCDPC Health Canada
T Sullivan PhD, CCO
B Whylie MD, Canadian Cancer Society

Please Note: The meeting previously scheduled for August 2003 in Montreal has been rescheduled for February 7th - 10th, 2004 in Nice, France. [details]

This page will remain online for historical purposes.

All prices are in US dollars, unless specified otherwise.